ATE215080T1 - 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen - Google Patents

1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Info

Publication number
ATE215080T1
ATE215080T1 AT99403133T AT99403133T ATE215080T1 AT E215080 T1 ATE215080 T1 AT E215080T1 AT 99403133 T AT99403133 T AT 99403133T AT 99403133 T AT99403133 T AT 99403133T AT E215080 T1 ATE215080 T1 AT E215080T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
production
compositions containing
dithiolane derivatives
aralkyl
Prior art date
Application number
AT99403133T
Other languages
English (en)
Inventor
Solo Golstein
Claude Guillonneau
Yves Charton
Pierre Lestage
Brian Lockhart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE215080T1 publication Critical patent/ATE215080T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
AT99403133T 1998-12-15 1999-12-14 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen ATE215080T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9815821A FR2787109B1 (fr) 1998-12-15 1998-12-15 Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE215080T1 true ATE215080T1 (de) 2002-04-15

Family

ID=9533988

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99403133T ATE215080T1 (de) 1998-12-15 1999-12-14 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Country Status (21)

Country Link
US (1) US6150358A (de)
EP (1) EP1010698B1 (de)
JP (1) JP3256787B2 (de)
KR (1) KR20000057059A (de)
CN (1) CN1131226C (de)
AT (1) ATE215080T1 (de)
AU (1) AU756213B2 (de)
BR (1) BR9908661A (de)
CA (1) CA2292248C (de)
DE (1) DE69901088D1 (de)
DK (1) DK1010698T3 (de)
EA (1) EA003424B1 (de)
ES (1) ES2174582T3 (de)
FR (1) FR2787109B1 (de)
HU (1) HUP9904592A3 (de)
NO (1) NO996179L (de)
NZ (1) NZ501783A (de)
PL (1) PL337172A1 (de)
PT (1) PT1010698E (de)
SI (1) SI1010698T1 (de)
ZA (1) ZA997707B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413707B1 (en) 2000-12-29 2002-07-02 Eastman Kodak Company Photographic element with yellow dye-forming coupler and stabilizing compound having improved light stability
US7202270B2 (en) * 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
JP2010520333A (ja) * 2007-03-01 2010-06-10 セダーズ−シナイ メディカル センター 〔1,2〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用
WO2009086547A1 (en) * 2008-01-03 2009-07-09 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
EP2300451A1 (de) * 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Prodrugs nichtsteroider entzündungshemmender mittel mit einer grösse im nanometerbereich
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos
US12152174B2 (en) * 2023-04-13 2024-11-26 The Regents Of The University Of California Adjustably stable adhesive compositions for medical and non-medical uses, and recycling
US12269925B1 (en) 2024-08-13 2025-04-08 The Regents Of The University Of California Fast curing, biocompatible and biodegradable adhesives and sealants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU586174A1 (ru) * 1976-04-26 1977-12-30 Уфимский Нефтяной Институт Способ получени 1,3-дитиациклоалканов
US4178291A (en) * 1976-12-03 1979-12-11 E. R. Squibb & Sons, Inc. Substituted acyl derivatives of amino acids
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
FR2707983A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés de l'acide lipoïque et dihydrolipoïque, leur préparation et leur application en thérapeutique humaine.
AU728488B2 (en) * 1997-04-02 2001-01-11 Sankyo Company Limited Dithiolan derivatives, their preparation and their therapeutic effect

Also Published As

Publication number Publication date
HU9904592D0 (en) 2000-02-28
JP2000178270A (ja) 2000-06-27
US6150358A (en) 2000-11-21
HK1027348A1 (en) 2001-01-12
AU6523899A (en) 2000-06-22
AU756213B2 (en) 2003-01-09
NZ501783A (en) 2000-09-29
PT1010698E (pt) 2002-07-31
CA2292248C (fr) 2004-04-13
EA003424B1 (ru) 2003-04-24
FR2787109A1 (fr) 2000-06-16
EA199901034A3 (ru) 2000-10-30
NO996179L (no) 2000-06-16
EP1010698A1 (de) 2000-06-21
CN1257072A (zh) 2000-06-21
DE69901088D1 (de) 2002-05-02
JP3256787B2 (ja) 2002-02-12
SI1010698T1 (en) 2002-06-30
DK1010698T3 (da) 2002-07-22
EA199901034A1 (ru) 2000-10-30
CN1131226C (zh) 2003-12-17
PL337172A1 (en) 2000-06-19
HUP9904592A3 (en) 2001-09-28
HUP9904592A2 (hu) 2001-04-28
EP1010698B1 (de) 2002-03-27
KR20000057059A (ko) 2000-09-15
BR9908661A (pt) 2000-10-17
FR2787109B1 (fr) 2001-01-19
ZA997707B (en) 2000-06-27
ES2174582T3 (es) 2002-11-01
CA2292248A1 (fr) 2000-06-15
NO996179D0 (no) 1999-12-14

Similar Documents

Publication Publication Date Title
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ATE215080T1 (de) 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
BRPI0413791A (pt) composto, método para o tratamento de um indivìduo humano ou animal que sofre de, ou que é suscetìvel a um distúrbio auto-imune ou uma condição inflamatória, uso de um composto, composição farmacêutica, e, processo para a prearação de compostos
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
ATE184280T1 (de) N-benzyl-indole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69217717D1 (de) Benzopyranderivate und Verfahren zu deren Herstellung
ATE119898T1 (de) Nmda-blockierende verbindungen, pharmazeutische präparate, deren herstellung und verwendung.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE281452T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE238985T1 (de) Hydroxamsäure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE3671016D1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ATE140216T1 (de) (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2001029017A3 (fr) 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES ET 1,4-THIOBUTYROLACTONES N-SUBSTITUEES UTILES COMME STIMULANT DE L'ACTIVITE DE L'ACIDE η-AMINOBUTYRIQUE ET DANS LE TRAITEMENT DES TROUBLES NERVEUX ET LEUR PROCEDE DE PREPARATION
ATE96144T1 (de) 2-aminoacetamid derivate.
DE69407227D1 (de) Die Verwendung von 2-Phenylmethylene-1-3'-(amino)-2-(hydroxy)-propoxy-imino-cyclohexane-Derivaten
DE60002759D1 (de) 3-imino-1,2-dithiolen derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee